Health Condition 1: D839- Common variable immunodeficiency,unspecified
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Children aged from 2-5 years of either sex 2. Childern with recurrent respiratory infections 3. Childern with recurrent G.I.T. diseases 4. Children with recurrent fever 5. Children with recuurent episodes of diarrhea 6. Children with other recurrent diseases
Exclusion criteria
Exclusion criteria: 1. Subjects suffering from major systemic illness necessitating long term treatment 2. Subjects with evidence of malignancy 3. Subject with aspartate amino transferase(AST) and or alanine amino transferase ALT >3 Times of the upper normal limit and renal dysfunction (Sr. creatinine >1.2mg/dl), uncontrolled pulmonary dysfunction( asthmatic and COPD patients) . 4. Co-morbidity like TB, UTI and bleeding disorders etc 5. Congenital anomalies and hereditary disease. 6. Pulmonary or abdominal tuberculosis. 7. H/O hypersensitivity to any of the trial drug or any of its ingredients. 8. Subjects who have completed participation in any other clinical trial during the past six months. 9. Any contraindications mentioned for Lehan karma in Kashyap Samhita.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To Observe the Immunomodulatory effect of Swarnaprashan.Timepoint: 8 weeks | — |
Secondary
| Measure | Time frame |
|---|---|
| Reduction in Morbidity rate in children.Timepoint: 8 weeks | — |
Countries
India
Contacts
National Institute of Ayurveda Jaipur, Rajasthan